CD39 expression defines exhausted CD4+ Tcells associatedwith poor survival and immune evasion in human gastric cancer.

Abstract

CD4+ Tcell helper and regulatory function in human cancers has been well characterised. However, the definition of tumor-infiltrating CD4+ Tcell exhaustion and how it contributes to the immune response and disease progression in human gastriccancer (GC) remain largely unknown. A total of 128 GC patients were enrolled in the study. The expression of CD39 and PD-1 on CD4+ Tcells in the different samples was analysed by flow cytometry. GC-infiltrating CD4+ Tcell subpopulations based on CD39 expression were phenotypically and functionally assessed. The role of CD39 in the immune response of GC-infiltrating Tcells was investigated by inhibiting CD39 enzymatic activity. In comparison with CD4+ Tcells from the non-tumor tissues, significantly more GC-infiltrating CD4+ Tcells expressed CD39. Most GC-infiltrating CD39+CD4+ Tcells exhibited CD45RA-CCR7- effector-memory phenotype expressing more exhaustion-associated inhibitory molecules and transcription factors and produced less TNF-α, IFN-γ and cytolytic molecules than their CD39-CD4+ counterparts. Moreover, ex vivo inhibition of CD39 enzymatic activity enhanced their functional potential reflected by TNF-α and IFN-γ production. Finally, increased percentages of GC-infiltrating CD39+CD4+ Tcells were positively associated with disease progression and patients' poorer overall survival. Our study demonstrates that CD39 expression defines GC-infiltrating CD4+ Tcell exhaustion and their immunosuppressive function. Targeting CD39 may be a promising therapeutic strategy for treating GC patients.